Lawlor Augustine
SEC-identified person · CIK 1262327 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| PRF Technologies Ltd. PRFX | Director | filed 2026 - 2026 |
| Leap Therapeutics, INC. LPTX | Chief Operating Officer | filed 2017 - 2025 |
| Targacept INC TRGT | Director | filed 2015 - 2023 |
| Replidyne INC RDYN | Director | filed 2006 - 2023 |
| Globeimmune INC GBIM | Director | filed 2014 - 2016 |
| Yumanity Therapeutics, INC. YMTX | Officer | filed 2016 - 2016 |
| Trevena INC TRVN | Officer | filed 2014 - 2014 |
| Tetralogic Pharmaceuticals Corp TLOG | Officer | filed 2013 - 2013 |
| Human Genome Sciences INC HGSI | Director | filed 2006 - 2012 |
| Radius Health, Inc. RDUS | Officer | filed 2011 - 2011 |
| Pharmathene, INC PIP | Officer | filed 2007 - 2010 |
| Threshold Pharmaceuticals INC THLDD | Officer | filed 2008 - 2009 |
| Activbiotics INC HAQ | Officer | filed 2007 - 2007 |
| Middlebrook Pharmaceuticals, Inc. MBRKQ | Officer | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.